1. Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial. (June 2019) Authors: Merle, Philippe; Blanc, Jean-Frederic; Phelip, Jean-Marc; Pelletier, Gilles; Bronowicki, Jean-Pierre; Touchefeu, Yann; Pageaux, Georges; Gerolami, René; Habersetzer, François; Nguyen-Khac, Eric; Casadei-Gardini, Andrea; Borbath, Ivan; Tran, Albert; Wege, Henning; Saad, Amr Shafik; Colombo, Massim... Journal: Lancet gastroenterology and hepatology Issue: Volume 4:Number 6(2019) Page Start: 454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗